2018 Annual Meeting | C171 - Actualización Sobre Opciones Terapéuticas para la Epilepsia Farmacorresistente

Date Wednesday 04/25/18

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Andres M. Kanner, MD, FAAN

Topic(s)

Learning Objectives Los participantes podrán reconocer el rol de FAEs de tercera generación en el tratamiento de PCE. Podrán decidir sobre el uso de técnicas quirúrgicas en la evaluación prequirúrgica de pacientes con epilepsia focal no-lesional y habrán adquirido los conceptos necesarios para poder escoger el tipo de neuromodulación más adecuada para el tratamiento de pacientes con epilepsia fármaco-resistente (ENV vs. EPNAT vs. NR).

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Tracks Spanish Language

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Interactive, Audience Participation, Panel Discussion

Event Timeline
03:30 PM - 03:35 PM	Luncheon	Introduction Andres M. Kanner, MD, FAAN
03:35 PM - 04:10 PM	Speaker	Update in Pharmacologic Treatments of Epilepsy Vicente J. Iragui-Madoz, MD, PhD
04:10 PM - 04:50 PM	Speaker	Update on Non-Pharmacologic Therapies in Epilepsy Andres M. Kanner, MD, FAAN
04:50 PM - 05:25 PM	Speaker	Challenging Cases of Treatment-Resistant Epilepsy: An Open Discussion Jose E. Cavazos, MD, PhD
05:25 PM - 05:30 PM	Closing Remarks	Closing Remarks Andres M. Kanner, MD, FAAN

Faculty Disclosures
Andres M. Kanner, MD, FAAN	Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. Dr. Kanner has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Foundation of America. Dr. Kanner has received personal compensation in the range of $500-$4,999 for serving as a Lecture at International meeting with Eisai.
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
Vicente J. Iragui-Madoz, MD, PhD	No disclosure on file

��ɫ��

��ɫ��